Lonza Group AG Signs Agreement to Acquire Large-Scale Biologics Site in Vacaville (US) from ... | | StockXpo

Try Stockxpo Premium

Lonza Group AG Signs Agreement to Acquire Large-Scale Biologics Site in Vacaville (US) from …

Published: Monday, March 25, 2024 · 11:40 PM  |  Updated: Monday, March 25, 2024 · 11:40 PM

📊 648 views

SHARE











Mar 20, 2024 / 01:00PM GMT
Operator

Ladies and gentlemen, welcome to the Lonza Investor Conference Call and Live Webcast. I am Sandra, the Chorus Call operator. (Operator Instructions) The conference is being recorded. (Operator Instructions) The conference must not be recorded for publication or broadcast. At this time, it’s my pleasure to hand over to Mr. Albert M. Baehny, CEO at interim and Chairman of the Board of Directors. Please go ahead, sir.

Albert M. Baehny – Lonza Group AG – Interim CEO & Chairman

Thank you for the introduction. Good morning, good afternoon, and thanks to you all for joining the short update call about our agreement to acquire the Vacaville site from Roche. I’m joined today by our CFO, Philippe Deecke; and the President of our Biologics division, Jean-Christophe Hyvert. We will share a few details of the acquisition, then take some time to answer your questions. Let me provide a short overview of the transaction.

Today, we have signed an agreement with Roche to acquire the Genentech large-scale biologics facility in Vacaville, California, for USD 1.2

MORE IN INSIDE INVESTMENT NEWS


Cisco AI Revenue Soars: Bullish Outlook for Networking Giant featured image

Cisco AI Revenue Soars: Bullish Outlook for Networking Giant

Published: Friday, November 13, 2026 · 9:39 AM


Nebius Shares Plunge 10%: A Warning on Cloud Capex & Outlook featured image

Nebius Shares Plunge 10%: A Warning on Cloud Capex & Outlook

Published: Thursday, November 12, 2026 · 8:27 AM

scroll to top